Vitamin B 12.

Methionine synthase needs methylcobalamin to move a methyl group from 5-methyltetrahydrofolate to homocysteine, so without B12 folate accumulates in that one methylated form and cannot re-enter the cycle. Folate alone can also mask the blood picture of low B12, which is why they are dosed together.

Methylfolate is the exact methyl donor that methionine synthase hands to cobalamin, so the two work as a unit at one enzyme. Supplying methylfolate without adequate B12 leaves the methyl group stuck.

B12 and folate remethylate homocysteine to methionine while pyridoxal 5-phosphate drives cystathionine beta-synthase, the route that sends it toward cysteine. Covering both keeps homocysteine moving in either direction.

Betaine homocysteine methyltransferase remethylates homocysteine using betaine instead of methylfolate and B12. The two routes back each other up, so the pair is standard in methylation formulas.

SAM-e gives up its methyl group and becomes homocysteine, which B12 and folate convert back to methionine and then to SAM-e again. Without the B12 step the cycle drains toward homocysteine.

Methylcobalamin serves methionine synthase in the cytosol while adenosylcobalamin serves methylmalonyl CoA mutase in the mitochondrion. A formula carrying both covers each enzyme without relying on interconversion.

The intrinsic factor and B12 complex binds its cubilin receptor in the ileum in a calcium dependent manner. Low ileal calcium slows that receptor mediated uptake step.

B12 supplies the one carbon units dividing red cell precursors need while iron is built into heme, so both must be present for normal red cell production. Low status in either shows up in the same blood indices.

Methionine synthase reductase, the flavoprotein that returns oxidised cobalamin to its active state, depends on FAD from riboflavin. Riboflavin status therefore affects how well the B12 in circulation actually functions.

Very high ascorbate concentrations can chemically degrade cobalamin, so large simultaneous doses are better separated. The effect is clearest in solution rather than in a dry tablet.

Cobalamin must be freed from food protein by pepsin and acid before intrinsic factor can bind it, so low stomach acid slows that release. Supplemental crystalline B12 bypasses much of this, which is why oral forms are less acid dependent.

Methionine synthase uses methylcobalamin to move a methyl group from 5-methyltetrahydrofolate onto homocysteine, regenerating methionine. Cobalamin availability therefore sets how much of the homocysteine pool is recycled by that route. This is settled enzymology. Homocysteine is a marker, not an outcome.

Choline is oxidised to betaine, which offers a second, folate-independent way to methylate homocysteine back to methionine. When cobalamin-dependent methionine synthase is running slowly, the betaine route carries more of the load. The two nutrients feed the same one-carbon pool from different directions.

Endogenous phosphatidylcholine synthesis by the PEMT route consumes three S-adenosylmethionine molecules per phosphatidylcholine made, drawing on the same methyl pool that cobalamin helps regenerate. Dietary phosphatidylcholine reduces demand on that route. The link is biochemical rather than a tested pairing.

Creatine synthesis is one of the largest single consumers of S-adenosylmethionine in the body, at the guanidinoacetate methyltransferase step. Supplemental creatine lowers how much endogenous synthesis is needed and so spares methyl groups whose regeneration depends on cobalamin and folate. Read it as methyl-pool arithmetic, not a measured combination effect.

Homocysteine has two fates: remethylation to methionine, which needs cobalamin, or transsulfuration to cystathionine and then cysteine, which needs vitamin B6. The two branches share a substrate, so the state of one shapes flux through the other. Supplying cysteine reduces the pull on that transsulfuration branch.

Cysteine produced from homocysteine by transsulfuration is the rate-limiting building block of glutathione. Cobalamin status shifts how much homocysteine goes down that branch rather than back to methionine. The relationship is mechanistic and measured as metabolite concentrations.

Taurine is made from cysteine, itself a downstream product of the transsulfuration branch that competes with cobalamin-dependent remethylation for homocysteine. The connection is real but several steps removed, so it is mechanistic context rather than a reason to dose the two together.

Adenosylcobalamin drives methylmalonyl-CoA mutase, the enzyme that converts propionyl-CoA derived from odd-chain fats and several amino acids into succinyl-CoA. Carnitine buffers surplus propionyl groups as propionylcarnitine when that step slows. Both sit on the same short-chain acyl handling route.

Propionyl-CoA carboxylase is a biotin enzyme and it feeds methylmalonyl-CoA straight into the adenosylcobalamin-dependent mutase step. The two cofactors sit one reaction apart on the same pathway, which is why organic acid profiles can look similar when either is short. Established biochemistry, no combination trial implied.

Food-bound B12 is attached to protein and has to be released by stomach acid and pepsin before it can bind haptocorrin and then intrinsic factor. Crystalline B12 in a supplement skips that step, which is why supplemental and food-bound forms behave differently in people with low gastric acid output. The dependency applies to the food-bound form specifically.

Cobalamin is built around a single cobalt ion held in a corrin ring. The metal is the reactive centre of both the methyl and adenosyl forms. Bacteria need cobalt in the fermentation medium to make the vitamin at all. Humans have no use for free cobalt as a nutrient, only for the assembled vitamin.

Activated charcoal adsorbs small molecules non-selectively in the gut lumen, so anything taken alongside it, including a water-soluble vitamin, can be bound and carried through. The interaction is generic to adsorbents rather than specific to cobalamin. Separating the two by several hours is the usual practice.